Peak Capital Management’s Amgen AMGN Stock Holding History

Peak Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-129	Closed	-$24K	–	66
2018 Q2	$24K	Buy	+129	New	+$22.8K	0.01%	108

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Peak Capital Management's AMGN Position: Q3 2018 in Review

Peak Capital Management sold out of Amgen (AMGN) in Q3 2018, closing a stake of 129 shares — an estimated $24K sold.

Peak Capital Management first reported a position in AMGN in Q2 2018 and held it in 1 quarter. The position peaked at $24K in Q2 2018. 1,796 funds tracked by Wall St. Rank hold AMGN as of Q3 2018.

Peak Capital Management reported no remaining Amgen position as of Q3 2018 after selling out during the quarter.
Peak Capital Management sold 129 Amgen shares in Q3 2018, an estimated $24K.
Peak Capital Management first reported a position in Amgen in Q2 2018 and held it in 1 quarter.
Peak Capital Management's Amgen position peaked at $24K in Q2 2018.
1,796 funds tracked by Wall St. Rank held Amgen as of Q3 2018.

Based on Peak Capital Management's 13F filing for Q3 2018, filed 20 Nov 2018.